UTHSC and Regional One Health Collaborate on COVID-19 Treatment Clinical
The University of Tennessee Health Science Center and Regional One Health have announced they are partnering on a clinical trial program including two late-stage clinical trials evaluating Regeneron’s REGN-COV2, the company’s investigational two-antibody cocktail for the treatment and prevention of COVID-19.